Clinical Trials
463 trialsA Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Memorial Sloan Kettering Cancer Center
Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.
Infanta Leonor University Hospital
Collection of Tissue Samples for Cancer Research
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
LEADER
Takeda
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
M.D. Anderson Cancer Center
Biomarker for Infection Risk in CLL and MM
Massachusetts General Hospital
COSMIC
ASH Research Collaborative
MUST
Pfizer
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MMAPPIN' Study: Multiple Myeloma Analysis For Patient-specific Insights to Dissect Disease Heterogeneity
IRCCS Azienda Ospedaliero-Universitaria di Bologna
LONGEVITI
University of Alberta
MoMMent
Janssen Pharmaceutica N.V., Belgium
REALiTEC/TAL
Janssen-Cilag Ltd.
iPREFER
The Christie NHS Foundation Trust
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Dana-Farber Cancer Institute
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Pfizer
ALPS
Fondazione IRCCS Policlinico San Matteo di Pavia
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Dana-Farber Cancer Institute
Tissue Collection for Studies of Lymph Cancer
National Institutes of Health Clinical Center (CC)
iCaRe2
University of Nebraska
RISE
Gruppo Italiano Malattie EMatologiche dell'Adulto
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
National Institutes of Health Clinical Center (CC)
Agriculture Health Study
National Institutes of Health Clinical Center (CC)
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
National Institutes of Health Clinical Center (CC)
COGNITOX
University of Aarhus
MARINA
iOMEDICO AG
VAMOS
University Hospital, Toulouse
CER
Cancer Support Community, Research and Training Institute, Philadelphia
PNRR-2022-1237
Azienda USL Reggio Emilia - IRCCS
Pre-malignant States to Hematologic Malignancies in Firefighters
Wake Forest University Health Sciences
Connect® MM- The Multiple Myeloma Disease Registry
Celgene
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Wake Forest University Health Sciences
RHUMM
Intergroupe Francophone du Myelome
TEC-CARE
Intergroupe Francophone du Myelome
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
The Royal Wolverhampton Hospitals NHS Trust
TRANSFORMM
University of Miami
Study of CAR-T Therapy in Older Patients
Memorial Sloan Kettering Cancer Center
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Shanxi Bethune Hospital
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
The First Hospital of Jilin University
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
Shanxi Bethune Hospital
B-SCR-MM
Ohio State University Comprehensive Cancer Center
MMExFFPE
BIWAKO
MM-t4-14-FFPE
BIWAKO
LTFS
Caribou Biosciences, Inc.
A Study of Ninlaro in Real World Clinical Practice in China
Takeda
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
GlycAL
Fondazione IRCCS Policlinico San Matteo di Pavia